 |
|
Apixaban for Secondary Stroke Prevention: Coexistant Cerebral Atherosclerosis May Increase Recurrent Strokes
Jong S. Kim, Jaseong Koo, Dong-Ick Shin, Byung-Su Kim, Jei Kim, Eung-Gyu Kim, Keun-Sik Hong, Hyeju Yi
J Stroke. 2022;24(1):118-127. Published online 2022 Jan 31 DOI: https://doi.org/10.5853/jos.2021.02355
|
|
Citations to this article as recorded by
 Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation
Ki-Woong Nam, Hyung-Min Kwon, Yong-Seok Lee, Sung-Ho Won, Hye-Sung Moon, Jong-Ho Park
Scientific Reports.2024;[Epub] CrossRef Occurrence of Ischemic Stroke in Patients With Atrial Fibrillation Receiving Non-Vitamin K Oral Anticoagulants: Causes and Prevention Strategies
Oh Young Bang, Kyoung-Min Park, Dong Seop Jeong
Journal of Stroke.2023; 25(2): 199. CrossRef Apixaban
Reactions Weekly.2022; 1913(1): 81. CrossRef
|